Doctors at NYU Langone’s Pancreatic Disease Program are recognized leaders in the diagnosis and treatment of diseases of the pancreas and caring for people who have or are at risk for these conditions. We treat you as a whole person—with the aim not only to improve your health but also to support your wellbeing.
Our team specializes in treating people with benign and malignant, or cancerous, diseases of the pancreas, including pancreatitis, pancreatic cysts, pancreatic tumors, and—in close collaboration with our team of experts at Perlmutter Cancer Center—pancreatic cancer. In addition, we offer genetic testing and counseling for people who may be at increased risk of developing pancreatic cancer due to family history or other risk factors.
Our multidisciplinary team of experts includes gastroenterologists and advanced endoscopists, pancreatic surgeons, oncology specialists, radiologists, and others who bring a patient-centered, comprehensive approach to your care.
We use the most sophisticated testing to provide you with a timely, accurate, and specific diagnosis, which is essential for effective treatment. We then develop a treatment plan that is tailored to your individual health and needs.
Preventive care is a cornerstone of our mission. Our team is expert in advanced endoscopic and surgical procedures that can prevent precancerous cysts from progressing to cancer, as well as strategies that help prevent the recurrence of pancreatitis and other conditions.
Because we are part of a world-class academic medical center, we offer the latest and most innovative medical and surgical treatments as well as the newest therapies being evaluated in clinical trials. Our highly skilled advanced endoscopy team performs state-of-the-art endoscopic procedures to diagnose and treat pancreatitis, pancreatic cysts, and some pancreatic tumors.
Some pancreatic conditions may require surgery. Our internationally renowned hepatobiliary and pancreatic surgeons are among the most experienced in the world. Together they have performed thousands of complex surgeries, including pancreaticoduodenectomy or Whipple procedure—a highly specialized procedure to remove cancer from the head of the pancreas—as well as total, distal, and central pancreatectomies. In addition, members of our surgical team are prominent in the field for their skill and expertise in removing advanced pancreatic tumors typically considered inoperable.
Our team is experienced in minimally invasive surgical procedures, including robotic-assisted and laparoscopic approaches, as well as traditional open surgery—all with excellent patient outcomes.
We also specialize in pancreas auto-islet transplantation for treatment of chronic pancreatitis. In this procedure the diseased pancreas is removed, but the islet cells—cells that produce insulin—are returned to your liver. An auto-islet transplant reduces the risk of developing diabetes after a pancreatectomy.
For people who have pancreatic cancer, our multidisciplinary team provides the most advanced diagnostic and treatment options available. We tailor every therapeutic regimen we use, including surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy, to each person’s specific health condition and needs.
The NYU Langone’s Pancreatic Disease Program team understands that pancreatic diseases can affect different aspects of your health and wellbeing. We offer a comprehensive approach to your care that includes pain management, nutrition counseling, and psychosocial support, which addresses the behavioral, social, and psychological aspects of living with pancreatic disease.
Our experts are at the forefront of using clinical trials to evaluate the effectiveness of promising new therapies and interventions for pancreatic conditions. People receiving care through our program gain access to these studies. Your doctor may discuss whether enrolling in a clinical trial is right for you.
View our active trials in the following areas:
For questions about our pancreatic cancer clinical trials, contact Pamela Baga, NP, at firstname.lastname@example.org or Chelsea Garcia, senior clinical research coordinator, at email@example.com.
For questions about clinical trials for other pancreatic conditions, contact Emil Agarunov at firstname.lastname@example.org.
Our team is helping to advance our understanding of pancreatic diseases, discover ways to detect them earlier, and design new, more effective treatments. As part of these efforts, we offer every person we treat the opportunity to participate in our long-term research.
The Pancreatic Disease Program is led by gastroenterologist and advanced endoscopy specialist Tamas A. Gonda, MD; medical oncologist Paul E. Oberstein, MD; and surgeons Diane M. Simeone, MD, and Christopher Wolfgang, MD, PhD.